A bélflóra patofiziológai jelentosége és szerepe mint terápiás célpont májbetegségekben

Hagymási Krisztina, Bacsárdi Anna, Egresi Anna, Berta Evelin, Tulassay Zsolt, Lengyel Gabriella

Research output: Review article

2 Citations (Scopus)

Abstract

The community of microorganisms in the intestine, namely gut microbiome lives in symbiosis with the host, contributing to its homeostasis and influencing it simultaneously. It can be suspected that gut microbiome plays a central role in the pathophysiology of intestinal and extraintestinal diseases: determining their development, progress and complications. Recently, intestinal microbiome has become a highlighted field of interest and important topic in research, especially in hepatology. It is in the focus of relevant research as the liver is the organ which meets nutrients, bacterial components, toxins and metabolites at first, as a filter. The evolvement of different liver diseases - just like alcoholic and non-alcoholic fatty liver disease, steatohepatitis, cirrhosis or hepatocellular carcinoma - correlates with the changed composition and activity of gut microbiome. Thus, it can be hypothesized that pre-, pro- and antibiotics could have an impact on the treatment of these diseases. In our review article, the relationship between intestinal flora and liver diseases with different etiologies as well as therapeutic possibilities are discussed.

Original languageHungarian
Pages (from-to)1465-1474
Number of pages10
JournalOrvosi Hetilap
Volume159
Issue number36
DOIs
Publication statusPublished - szept. 1 2018

Fingerprint

Liver Diseases
Chronic Disease
Intestinal Diseases
Bacterial Toxins
Symbiosis
Probiotics
Gastroenterology
Fatty Liver
Research
Intestines
Hepatocellular Carcinoma
Homeostasis
Fibrosis
Gastrointestinal Microbiome
Anti-Bacterial Agents
Food
Liver
Therapeutics

Keywords

  • Dysbiosis
  • Gut permeability
  • Liver diseases
  • Microbiome
  • Microbiota
  • Prebiotics
  • Probiotics
  • Rebiosis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A bélflóra patofiziológai jelentosége és szerepe mint terápiás célpont májbetegségekben. / Krisztina, Hagymási; Anna, Bacsárdi; Anna, Egresi; Evelin, Berta; Zsolt, Tulassay; Gabriella, Lengyel.

In: Orvosi Hetilap, Vol. 159, No. 36, 01.09.2018, p. 1465-1474.

Research output: Review article

@article{935631d9a6be42399f40d3ad037d4b49,
title = "A b{\'e}lfl{\'o}ra patofiziol{\'o}gai jelentos{\'e}ge {\'e}s szerepe mint ter{\'a}pi{\'a}s c{\'e}lpont m{\'a}jbetegs{\'e}gekben",
abstract = "The community of microorganisms in the intestine, namely gut microbiome lives in symbiosis with the host, contributing to its homeostasis and influencing it simultaneously. It can be suspected that gut microbiome plays a central role in the pathophysiology of intestinal and extraintestinal diseases: determining their development, progress and complications. Recently, intestinal microbiome has become a highlighted field of interest and important topic in research, especially in hepatology. It is in the focus of relevant research as the liver is the organ which meets nutrients, bacterial components, toxins and metabolites at first, as a filter. The evolvement of different liver diseases - just like alcoholic and non-alcoholic fatty liver disease, steatohepatitis, cirrhosis or hepatocellular carcinoma - correlates with the changed composition and activity of gut microbiome. Thus, it can be hypothesized that pre-, pro- and antibiotics could have an impact on the treatment of these diseases. In our review article, the relationship between intestinal flora and liver diseases with different etiologies as well as therapeutic possibilities are discussed.",
keywords = "Dysbiosis, Gut permeability, Liver diseases, Microbiome, Microbiota, Prebiotics, Probiotics, Rebiosis",
author = "Hagym{\'a}si Krisztina and Bacs{\'a}rdi Anna and Egresi Anna and Berta Evelin and Tulassay Zsolt and Lengyel Gabriella",
year = "2018",
month = "9",
day = "1",
doi = "10.1556/650.2018.31178",
language = "Hungarian",
volume = "159",
pages = "1465--1474",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "36",

}

TY - JOUR

T1 - A bélflóra patofiziológai jelentosége és szerepe mint terápiás célpont májbetegségekben

AU - Krisztina, Hagymási

AU - Anna, Bacsárdi

AU - Anna, Egresi

AU - Evelin, Berta

AU - Zsolt, Tulassay

AU - Gabriella, Lengyel

PY - 2018/9/1

Y1 - 2018/9/1

N2 - The community of microorganisms in the intestine, namely gut microbiome lives in symbiosis with the host, contributing to its homeostasis and influencing it simultaneously. It can be suspected that gut microbiome plays a central role in the pathophysiology of intestinal and extraintestinal diseases: determining their development, progress and complications. Recently, intestinal microbiome has become a highlighted field of interest and important topic in research, especially in hepatology. It is in the focus of relevant research as the liver is the organ which meets nutrients, bacterial components, toxins and metabolites at first, as a filter. The evolvement of different liver diseases - just like alcoholic and non-alcoholic fatty liver disease, steatohepatitis, cirrhosis or hepatocellular carcinoma - correlates with the changed composition and activity of gut microbiome. Thus, it can be hypothesized that pre-, pro- and antibiotics could have an impact on the treatment of these diseases. In our review article, the relationship between intestinal flora and liver diseases with different etiologies as well as therapeutic possibilities are discussed.

AB - The community of microorganisms in the intestine, namely gut microbiome lives in symbiosis with the host, contributing to its homeostasis and influencing it simultaneously. It can be suspected that gut microbiome plays a central role in the pathophysiology of intestinal and extraintestinal diseases: determining their development, progress and complications. Recently, intestinal microbiome has become a highlighted field of interest and important topic in research, especially in hepatology. It is in the focus of relevant research as the liver is the organ which meets nutrients, bacterial components, toxins and metabolites at first, as a filter. The evolvement of different liver diseases - just like alcoholic and non-alcoholic fatty liver disease, steatohepatitis, cirrhosis or hepatocellular carcinoma - correlates with the changed composition and activity of gut microbiome. Thus, it can be hypothesized that pre-, pro- and antibiotics could have an impact on the treatment of these diseases. In our review article, the relationship between intestinal flora and liver diseases with different etiologies as well as therapeutic possibilities are discussed.

KW - Dysbiosis

KW - Gut permeability

KW - Liver diseases

KW - Microbiome

KW - Microbiota

KW - Prebiotics

KW - Probiotics

KW - Rebiosis

UR - http://www.scopus.com/inward/record.url?scp=85052676001&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052676001&partnerID=8YFLogxK

U2 - 10.1556/650.2018.31178

DO - 10.1556/650.2018.31178

M3 - Review article

C2 - 30175608

AN - SCOPUS:85052676001

VL - 159

SP - 1465

EP - 1474

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 36

ER -